| |
| |
|
| Insider
Information: |
Stack David M |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
186,481 |
|
|
Indirect Shares
|
156,184 |
|
|
| Direct
Value |
$4,755,266 |
|
|
|
Indirect Value
|
$2,997,096 |
|
|
| Total
Shares |
342,665 |
|
|
| Total
Value |
$7,752,362 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
5
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
3
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
 -15.8%
|
 67.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
CEO and Chairman, Dire... |
2023-06-14 |
186,481 |
2023-06-14 |
116,184 |
Premium* |
|
|
Amarin Corp Plc |
AMRN |
Director |
2019-05-29 |
0 |
2021-06-04 |
40,000 |
Premium* |
|
|
Chiasma, Inc |
CHMA |
Director |
2020-11-30 |
0 |
2021-08-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
32,700 |
186,481 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2023-06-07 |
4 |
S |
$37.87 |
$201,669 |
D/D |
(5,326) |
153,781 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2023-06-06 |
4 |
S |
$38.99 |
$197,216 |
D/D |
(5,058) |
159,107 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
21,500 |
163,751 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-06-08 |
4 |
AS |
$59.10 |
$827,658 |
D/D |
(13,828) |
142,251 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-06-06 |
4 |
AS |
$61.37 |
$734,340 |
D/D |
(11,965) |
156,079 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-04-28 |
4 |
OE |
$10.81 |
$243,225 |
D/D |
22,500 |
168,044 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-03-31 |
4 |
OE |
$10.81 |
$243,225 |
D/D |
22,500 |
145,544 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-01-25 |
4 |
OE |
$10.81 |
$147,773 |
D/D |
13,670 |
123,044 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2022-01-11 |
4 |
OE |
$10.81 |
$162,150 |
D/D |
15,000 |
109,374 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-11-16 |
4 |
OE |
$10.81 |
$162,150 |
D/D |
15,000 |
94,085 |
0 |
- |
|
| CHMA |
Chiasma, Inc |
Director |
– • – |
2021-08-05 |
4 |
D |
$0.00 |
$0 |
I/I |
(25,000) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
17,800 |
78,956 |
0 |
- |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2021-06-04 |
4 |
B |
$4.54 |
$45,350 |
I/I |
10,000 |
40,000 |
2.1 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-06-04 |
4 |
S |
$61.04 |
$909,756 |
D/D |
(14,905) |
61,156 |
0 |
% |
|
| AMRN |
Amarin Corp Plc |
Director |
– • – |
2021-06-03 |
4 |
B |
$4.62 |
$23,115 |
I/I |
5,000 |
30,000 |
2.1 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-05-12 |
4 |
AS |
$60.76 |
$1,316,471 |
D/D |
(21,250) |
76,061 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-05-12 |
4 |
OE |
$10.81 |
$229,713 |
D/D |
21,250 |
97,311 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-05-11 |
4 |
AS |
$60.78 |
$1,294,827 |
D/D |
(21,250) |
76,061 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-05-11 |
4 |
OE |
$10.81 |
$229,713 |
D/D |
21,250 |
97,311 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-03-24 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,080 |
97,273 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-02-03 |
4 |
AS |
$70.78 |
$1,513,259 |
D/D |
(21,250) |
76,061 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-02-03 |
4 |
OE |
$10.81 |
$229,713 |
D/D |
21,250 |
97,311 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-02-02 |
4 |
AS |
$68.41 |
$1,474,874 |
D/D |
(21,250) |
76,061 |
0 |
% |
|
| PCRX |
Pacira Pharmaceuticals, I... |
CEO and Chairman |
• • – |
2021-02-02 |
4 |
OE |
$10.81 |
$229,713 |
D/D |
21,250 |
97,311 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
